Osteopathy in mild adrenal Cushing's syndrome and Cushing disease
- PMID: 33795196
- DOI: 10.1016/j.beem.2021.101515
Osteopathy in mild adrenal Cushing's syndrome and Cushing disease
Abstract
Pathophysiology and effects of endogenous glucocorticoid (GC) excess on skeletal endpoints as well as awareness and management of bone fragility are reviewed. Cushing's syndrome (CS) increase the risk of fracture affecting prevalently bone quality. Bone antiresorptive agents (SERMs, bisphosphonates and denosumab) as well as teriparatide increase bone mineral density and in some instances reduce fracture risk. Awareness and management of bone health in CS can be improved.
Keywords: adrenal incidentaloma; bone mineral density; bone quality; cushing disease; fractures; glucocorticoids.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
